NGENLA sol inj 60 mg/1.2ml stylo pré
7680682650026
CH-68265
H01AC08
07.03.1.
Active substances:
1 / 2
google
Details
- Product number
- 6826502
- CPT
- -
- Packaging group
- 1.2
- Unit
- ml
- Composition
- somatrogonum 60 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, metacresolum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml corresp. natrium 4.8 mg.
Articles (1)
Ngenla 60 mg/ 1.2 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1.2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
somatrogonum
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
metacresolum
|
- | Substance | Konservierungsstoff (Conservateur) |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
4.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 790.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 68265
- Drug name
- Ngenla, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H01AC08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/09/2022
- Authorization expiration date
- 08/09/2027
- IT number
- 07.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NGENLA sol inj 60 mg/1.2ml stylo pré
- Description (DE)
- NGENLA Inj Lös 60 mg/1.2ml Fertpen
- Market launch
- 09/09/2022
- Narcotic (BTM)
- No